Cours CytoDyn Inc. Other OTC
Actions
CYDY
US23283M1018
Recherche biotechnologique et médicale
CA 2022 | 0,27 0,24 | CA 2023 | - | Capitalisation | 239 M 218 M |
---|---|---|---|---|---|
Résultat net 2022 | -211 M -192 M | Résultat net 2023 | -79 M -71,78 M | VE / CA 2022 | 989 524 989 x |
Dette nette 2022 | 32,57 M 29,59 M | Dette nette 2023 | 33,01 M 29,99 M | VE / CA 2023 | - |
PER 2022 |
-1,02
x | PER 2023 |
-2,52
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 99,15% |
Dernier transcript sur CytoDyn Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 65 | 17/11 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | 01/02 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 03/05/23 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 13/10/22 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 24/08/22 |
Karen Brunke
BRD | Director/Board Member | 72 | 01/04/22 |
Varia. 1 janv. | Capi. | |
---|---|---|
+8,29% | 114 Md | |
+10,21% | 104 Md | |
-11,90% | 22,41 Md | |
+0,44% | 22,28 Md | |
-5,61% | 19,07 Md | |
-37,36% | 18 Md | |
-5,17% | 17,89 Md | |
+7,70% | 14,28 Md | |
+37,65% | 12,55 Md |